Your browser doesn't support javascript.
loading
Transition in Sickle Cell Disease (SCD): A German Consensus Recommendation.
Alashkar, Ferras; Aramayo-Singelmann, Carmen; Böll, Janine; Hoferer, Annette; Jarisch, Andrea; Kamal, Haytham; Oevermann, Lena; Schwarz, Michaela; Cario, Holger.
Afiliación
  • Alashkar F; Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.
  • Aramayo-Singelmann C; Department of Pediatrics III, University Children's Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.
  • Böll J; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, University Hospital of Cologne, 50923 Cologne, Germany.
  • Hoferer A; Hematology/Oncology Department for Adolescent Medicine, Robert-Bosch-Hospital, 70376 Stuttgart, Germany.
  • Jarisch A; Department for Children and Adolescents, Division for Stem Cell Transplantation and Immunology, University Hospital Frankfurt, 60590 Frankfurt am Main, Germany.
  • Kamal H; Joint Practice for Hematology and Oncology, 30625 Hannover, Germany.
  • Oevermann L; Department of Pediatric Oncology & Hematology, Charité University Medicine, 10117 Berlin, Germany.
  • Schwarz M; Department of Hematology, Oncology, and Tumor Immunology, Charité University Medicine, 10117 Berlin, Germany.
  • Cario H; Department of Pediatrics and Adolescent Medicine & Center for Rare Hematopoietic Disorders and Immunodeficiencies (ZSHI Ulm), Ulm University Medical Center, 89069 Ulm, Germany.
J Pers Med ; 12(7)2022 Jul 17.
Article en En | MEDLINE | ID: mdl-35887653

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: J Pers Med Año: 2022 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: J Pers Med Año: 2022 Tipo del documento: Article País de afiliación: Alemania